Amniotic Membrane Transplantation—a New Approach to Crossing the HLA Barriers in the Treatment of Refractory Ocular Graft-Versus-Host Disease

Bone Marrow Transplantation - United Kingdom
doi 10.1038/s41409-018-0140-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Sirolimus for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2009English

Ruxolitinib as a Promising Treatment for Corticosteroid-Refractory Graft-Versus -Host Disease

British Journal of Haematology
Hematology
2017English

PROSE Treatment in Ocular Graft Versus Host Disease; A Five Year Follow-Up

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Response to Thalidomide Therapy in Refractory Chronic Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2000English

Etanercept as Treatment of Steroid-Refractory Acute Graft Versus Host Disease in Pediatric Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Tocilizumab for Steroid Refractory Acute Graft-Versus-Host Disease

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2015English

Imatinib Mesylate for the Treatment of Steroid-Refractory Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Serum Vitamin a Levels May Affect the Severity of Ocular Graft-Versus-Host Disease

Frontiers in Medicine
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy